Daniel E. Singer

Jan 8, 2025 | thenation.com | David Bell |Daniel E. Singer

Obituary / January 8, 2025 The Toxic Legacy of Jean-Marie Le PenThe elder Le Pen is dead, but far-right populists across the world still echo his mix of violent rhetoric, brazen lies, and outreach to mainstream conservatives. Ad Policy Founder of the far-right National Front party Jean-Marie Le Pen points his finger as he poses during a photo session at his home in Saint-Cloud on January 14, 2021.

Jan 1, 2025 | jacc.org | Daniel E. Singer |Steven J. Atlas |Alan S. Go |Steven A. Lubitz

Introduction Recent trials of one-time brief electrocardiographic (ECG) screening for atrial fibrillation (AF) have not shown a significant increase in diagnosed AF compared to usual care.1–3 By contrast, longer-term continuous ECG monitoring detected substantially more AF cases, primarily paroxysmal atrial fibrillation (PAF).4-7 By identifying and treating AF earlier, the goal of screening is to reduce the risk of future cardiovascular events, primarily ischemic stroke.8,9 Although the...

Nov 22, 2023 | stagewhispers.com.au | Adam Long |Daniel E. Singer

The Reduced Shakespeare Company’s madcap medley of Shakespeare’s plays has once again appeared in the fair city of Verona [strike that: Canberra! – Ed] Canberra, with Canberra Repertory bravely challenging the Bard to cut all the excess verbiage and condense his entire oeuvre to its most essential 97 minutes.

Sep 2, 2023 | dovepress.com | Lily G Bessette |Daniel E. Singer |Ajinkya Pawar |Vincent Wong

Back to Journals » Clinical Epidemiology » Volume 16 Authors Bessette LG , Singer DE , Pawar A, Wong V, Kim DH , Lin KJ Received 2 September 2023 Accepted for publication 7 February 2024 Published 17 April 2024 Volume 2024:16 Pages 267—279 DOI https://doi.org/10.2147/CLEP.S438013 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Laura Horsfall Lily G Bessette,1 Daniel E Singer,2 Ajinkya Pawar,1 Vincent Wong,1 Dae...

Aug 18, 2023 | onlinelibrary.wiley.com | Alan John Camm |Saverio Virdone |Daniel E. Singer |Jean P. Bassand

1 INTRODUCTION Patients with atrial fibrillation (AF) have five times higher risk of stroke and two times higher risk of all-cause mortality compared to the age-matched general population.1 Standard of care for mitigating stroke risk is prophylactic oral anticoagulant (OAC) therapy using vitamin K antagonists (VKAs) or non-VKA oral anticoagulants (NOACs). However, the benefit of these drugs must be balanced against an increased risk of bleeding.